Life Extension Magazine

Life Extension Magazine July 2014

Report

New Health Benefits From Daily Coffee

By Jeffrey Huntington

Coffee Prevents Liver And Kidney Cancers

The rich brew of bioactive compounds in coffee is now credited with preventing certain cancers, particularly those of the liver and kidneys.18

Hepatocellular carcinoma is the most common primary malignant cancer of the liver; it is strongly associated with hepatitis B and C viral infections, and coffee drinking appears to confer a protective effect.68

Compared with people drinking 0-1 cups of coffee/day, those drinking 2-3, 4-5, 6-7, and 8 or more cups/day have reductions in liver cancer risk of 34, 56, 62, and 68%, respectively.17 This level of protection is provided by coffee, regardless of whether a person has been infected with either or both hepatitis B and C viruses, both of which are strongly associated with liver cancer.69 Overall, studies show a remarkably consistent average risk reduction of about 50% in coffee drinkers versus non-drinkers, regardless of study design or location.70

Proposed mechanisms for protection against liver cancer include induction of toxin-destroying and anti-oxidant enzymes, and reducing enzymes that activate carcinogens.18

Coffee consumption appears to reduce kidney cancer risk as well, with laboratory evidence demonstrating that coffee helps destroy renal cancer cells.18,19 Compelling evidence also shows general improvements in kidney function among coffee drinkers.

Several studies have now shown that coffee significantly increases kidney function as measured by glomerular filtration rate (GFR), the amount of toxin-containing fluid that is filtered through the kidney each minute (higher numbers are better).71,72 The effect was demonstrated to be even greater in middle-aged and elderly coffee-consuming female diabetics.73 And among kidney dialysis patients, coffee drinking is associated with significant improvements in lipid profile, a cardiovascular risk increases in those on dialysis.74

Summary

Coffee, one of the world’s most popular beverages, is a complicated mix of more than a thousand compounds. In addition to caffeine, which itself appears to have beneficial effects, coffee also contains polyphenols and other compounds capable of modifying gene expression, protecting tissues from oxidant and inflammatory damage, and other favorable effects.

A major study demonstrated that coffee drinkers are at significantly lower risk of dying from all causes, as well as from many of the specific conditions that are the leading cause of death among Americans, from cardiovascular disease to diabetes. Additional studies have shown benefits from coffee consumption on metabolic syndrome, neurodegenerative diseases, and cancers of the kidney and liver.

So, find a brand of coffee that you enjoy, preferably one with known quantities of antioxidant molecules, and drink up—you’ll be doing yourself and your health a pleasurable favor.

If you have any questions on the scientific content of this article, please call a Life Extension® Health Advisor at 1-866-864-3027.

References

  1. Buscemi S, Verga S, Batsis JA, et al. Acute effects of coffee on endothelial function in healthy subjects. Euro J Clin Nutr. 2010 May;64(5):483-9.
  2. O’Keefe JH, Bhatti SK, Patil HR, et al. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013 Sep 17;62(12):1043-51.
  3. Imatoh T, Tanihara S, Miyazaki M, et al. Coffee consumption but not green tea consumption is associated with adiponectin levels in Japanese males. Eur J Nutr. 2011 Jun;50(4):279-84.
  4. Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Europ J Nutr. 2014 Feb;53(1):25-38.
  5. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specificmortality. NEJM. 2012 May 17;366(20): 1891-904.
  6. Shechter M, Shalmon G, Scheinowitz M, et al. Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease. Amer J Cardiolog. 2011 May 1;107(9):1255-61.
  7. O’Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013 Sep 17;62(12):1043-51.
  8. Lee KW, Im JY, Woo JM, et al. Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson’s disease. Neurotherapeutics. 2013 Jan;10(1):143-53.
  9. Huber WW, Parzefall W. Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk. Methods Enzymol. 2005;401:307-41.
  10. Cavin C, Holzhaeuser D, Scharf G, et al.Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol. 2002 Aug;40(8):1155-63.
  11. Murase T, Misawa K, Minegishi Y, et al. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab . 2011 Jan;300(1):E122-33.
  12. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. Feb 11 2014;129(6):643-59.
  13. Takami H, Nakamoto M, Uemura H, et al. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. Japan Epidemiological Association. 2013;23(1):12-20.
  14. Mure K, Maeda S, Mukoubayashi C, et al. Habitual coffee consumption inversely associated with metabolic syndrome-related biomarkers involving adiponectin. Nutr. 2013; Jul-Aug 29(7-8):982-7.
  15. Buscemi S, Batsis JA, Arcoleo G, Verga S. Coffee and endothelial function: a battle between caffeine and antioxidants? Eur J Clin Nutr. 2010 Oct;64(10):1242-3.
  16. Siasos G, Oikonomou E, Chrysohoou C, et al. Consumption of a boiled Greek type of coffee is associated with improved endothelial function: the Ikaria study. Vascu Med. 2013 Apr;18(2):55-62.
  17. Hu G, Tuomilehto J, Pukkala E, et al. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology. 2008 Jul;48(1):129-36.
  18. Nkondjock A. Coffee consumption and the risk of cancer: an overview. Cancer Lett. 2009 May 18;277(2):121-5.
  19. Choi MJ, Park EJ, Oh JH, et al. Cafestol, a coffee-specific diterpene, induces apoptosis in renal carcinoma Caki cells through down-regulation of anti-apoptotic proteins and Akt phosphorylation. Chem Biol Interact. 2011 Apr 25;190(2-3):102-8.
  20. Di Castelnuovo A, di Giuseppe R, Iacoviello L, de Gaetano G. Consumption of cocoa, tea and coffee and risk of cardiovascular disease. Euro J Intern Med. 2012 Jan;23(1):15-25.
  21. Rebello SA, van Dam RM. Coffee consumption and cardiovascular health: getting to the heart of the matter. Curr Cardiol Reports. 2013 Oct;15(10):403.
  22. Tangney CC, Rasmussen HE. Polyphenols, inflammation, and cardiovascular disease. Curr Atherosclerosis Rep. 2013 May;15(5):324.
  23. Ochiai R, Sugiura Y, Shioya Y, Otsuka K, Katsuragi Y, Hashiguchi T. Coffee polyphenols improve peripheral endothelial function after glucose loading in healthy male adults. Nutrition Research. 2014 Feb;34(2):155-9.
  24. Kishimoto Y, Tani M, Kondo K. Pleiotropic preventive effects of dietary polyphenols in cardiovascular diseases. Eur J Clin Nutr. 2013 May;67(5):532-5.
  25. Kim B, Nam Y, Kim J, Choi H, Won C.Coffee Consumption and Stroke Risk: A Meta-analysis of Epidemiologic Studies. Korean J Fam Med. 2012 Nov;33(6):356-65.
  26. Lind L, Berglund L, Larsson A, Sundstrom J. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation. 2011 Apr 12;123(14):1545-51.
  27. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998 May 15;91(10):3527-61.
  28. Crowther MA. Pathogenesis of atherosclerosis. Hematology Am Soc Hematol Educ Program. 2005:436-41.
  29. Papamichael CM, Aznaouridis KA, Karatzis EN, et al. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci. 2005 Jul;109(1):55-60.
  30. Umemura T, Ueda K, Nishioka K, et al. Effects of acute administration of caffeine on vascular function. American J Cardiol. 2006 Dec 1;98(11):1538-41.
  31. Buscemi S, Verga S, Batsis JA, et al. Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur J Clin Nutr. 2009 Oct;63(10):1200-5.
  32. Lacroix S, Rosiers CD, Tardif JC, Nigam A. The role of oxidative stress in postprandial endothelial dysfunction. Nutrition Res Rev. Dec 2012;25(2):288-301.
  33. Torimoto K, Okada Y, Mori H, Tanaka Y. Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc Diabetol. 2013;12:1.
  34. Mah E, Bruno RS. Postprandial hyperglycemia on vascular endothelial function: mechanisms and consequences. Nutri Res. Oct 2012;32(10):727-40.
  35. Buscemi S, Mattina A, Tranchina MR, Verga S. Acute effects of coffee on QT interval in healthy subjects. Nutr J. 2011;10:15.
  36. Wierzejska R, Jarosz M. Coffee drinking and risk of type 2 diabetes mellitus. Optimistic scientific data. Przegl Epidemiol. 2012;66(3):509512.
  37. Matsuura H, Mure K, Nishio N, Kitano N, Nagai N, Takeshita T. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol/JEA. 2012;22(2):160-6.
  38. Crawford MA. Diet and cancer and heart disease. Nutr Health. 2014 Mar 11.
  39. Orozco-Solis R, Sassone-Corsi P.Epigenetic control and the circadian clock: Linking metabolism to neuronal responses. Neuroscience. 2014 Apr 4;264C:76-87.
  40. Grantham JP, Staub K, Rühli FJ, Henneberg M. Modern diet and metabolic variance­—a recipe for disaster? Nutr J. 2014 Feb 6;13:15
  41. Watts AS, Loskutova N, Burns JM, Johnson DK.Metabolic syndrome and cognitive decline in early Alzheimer’s disease and healthy older adults. J Alzheimers Dis. 2013;35(2):253-65.
  42. Hsu IR, Kim SP, Kabir M, Bergman RN. Metabolic syndrome, hyperinsulinemia, and cancer. Am J Clin Nutr. 2007 Sep;86(3):s867-71.
  43. Hino A, Adachi H, Enomoto M, et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Prac. Jun 2007;76(3):383-9.
  44. Kamon J, Yamauchi T, Terauchi Y, Kubota N, Kadowaki T.The mechanisms by which PPARgamma and adiponectin regulate glucose and lipid metabolism. Nihon Yakurigaku Zasshi. 2003 Oct;122(4):294-300.
  45. Panchal SK, Poudyal H, Waanders J, Brown L. Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J Nutr. 2012 Apr;142(4):690-7.
  46. Fukushima Y, Kasuga M, Nakao K, Shimomura I, Matsuzawa Y. Effects of coffee on inflammatory cytokine gene expression in mice fed high-fat diets. J Agricult Food Chem. 2009 Dec 9;57(23):11100-5.
  47. Abrahao SA, Pereira RG, de Sousa RV, Lima AR, Crema GP, Barros BS. Influence of coffee brew in metabolic syndrome and type 2 diabetes. Plant Foods Hum Nutr. 2013 Jun;68(2):184-9.
  48. Yesil A, Yilmaz Y. Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. Nov 2013;38(9):1038-44.
  49. Grundy SM. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2012 Feb 14;59(7):635-43
  50. Doo T, Morimoto Y, Steinbrecher A, Kolonel LN, Maskarinec G. Coffee intake and risk of type 2 diabetes: the Multiethnic Cohort. Public Health Nutr . Feb 27 2013:1-9.
  51. Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. Feb 2014 Feb;37(2):569-86.
  52. Jia H, Aw W, Egashira K, et al. Coffee intake mitigated inflammation and obesity-induced insulin resistance in skeletal muscle of high-fat diet-induced obese mice. Genes Nutr. 2014 May;9(3):389.
  53. Takahashi S, Saito K, Jia H, Kato H. An integrated multi-omics study revealed metabolic alterations underlying the effects of coffee consumption. PloS one. 2014;9(3):e91134.
  54. Cao C, Wang L, Lin X, et al. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer’s mice. JAD. 2011;25(2):323-35.
  55. Chen JF, Xu K, Petzer JP, et al. Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson’s disease. J Soc Neuro. 2001 May 15;21(10):Rc143.
  56. Hermansen K, Krogholm KS, Bech BH, et al. Coffee can protect against disease. Ugeskrift Laeger. 2012 Sep 24;174(39):2293-7.
  57. Hu N, Yu JT, Tan L, Wang YL, Sun L, Tan L. Nutrition and the risk of Alzheimer’s disease. BioMed Res Int. 2013;2013:524820.
  58. Lee KW, Im JY, Woo JM, et al. Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson’s disease. Neurotherapeutics. Jan 2013;10(1):143-153.
  59. Palacios N, Gao X, McCullough ML, et al. Caffeine and risk of Parkinson’s disease in a large cohort of men and women. Mov Disord. Sep 1 2012;27(10):1276-82.
  60. Cao C, Loewenstein DA, Lin X, et al. High Blood caffeine levels in MCI linked to lack of progression to dementia. J Alzheimer’s Dis. 2012;30(3):559-72.
  61. Vercambre MN, Berr C, Ritchie K, Kang JH. Caffeine and cognitive decline in elderly women at high vascular risk. J Alzheimer’s Dis. 2013;35(2):413-21.
  62. Qi H, Li S. Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson’s disease. Geriatr Gerontol Int. 2013 Jul 23 .
  63. Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer’s disease. JAD. 2010;20 Suppl 1:S117-26.
  64. Cao C, Wang L, Lin X, et al. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer’s mice. J Alz Dis. 2011;25:323-335.
  65. Lucas M, Mirzaei F, Pan A, et al. Coffee, caffeine, and risk of depression among women. Arch Intern Med. 2011 Sep 26;171(17):1571-8.
  66. Pham NM, Nanri A, Kurotani K, et al. Green tea and coffee consumption is inversely associated with depressive symptoms in a Japanese working population. Public Health Nutr. 2014 Mar;17(3):625-33.
  67. Ruusunen A, Lehto SM, Tolmunen T, Mursu J, Kaplan GA, Voutilainen S. Coffee, tea and caffeine intake and the risk of severe depression in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Public Health Nutr. 2010 Aug;13(8):1215-20.
  68. Montella M, Crispo A, Giudice A. HCC, diet and metabolic factors: Diet and HCC. Hepat Mon. 2011 Mar;11(3):159-62.
  69. Inoue M, Kurahashi N, Iwasaki M, et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1746-53.
  70. Sang LX, Chang B, Li XH, Jiang M. Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC gastroenterol. 2013;13:34.
  71. Nakajima K, Hirose K, Ebata M, Morita K, Munakata H. Association between habitual coffee consumption and normal or increased estimated glomerular filtration rate in apparently healthy adults. Br J Nutr. 2010 Jan;103(2):149-52.
  72. Saito M, Nemoto T, Tobimatsu S, Ebata M, Le Y, Nakajima K. Coffee consumption and cystatin-C-based estimated glomerular filtration rates in healthy young adults: results of a clinical trial. J Nutr Metab. 2011;2011:146865.
  73. Kim BH, Park YS, Noh HM, Sung JS, Lee JK. Association between Coffee Consumption and Renal Impairment in Korean Women with and without Diabetes: Analysis of the Fourth Korea National Health and Nutrition Examination Survey in 2008. Korean J Fam Med. 2013 Jul;34(4):265-71.
  74. Grzegorzewska AE, Mlot-Michalska M, Wobszal P. Does ingestion of regular coffee influence serum lipid profile in dialysis patients? Adv Perit Dial. 2009;25:181-6.
  75. Hwang SJ, Kim YW, Park Y, Lee HJ, Kim KW. Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm Res. 2014 Jan;63(1):81-90.
  76. Lang R, Dieminger N, Beusch A, et al. Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal Bioanal Chem. 2013 Oct;405(26):8487-503.
  77. Li Y, Shen D, Tang X, et al. Chlorogenic acid prevents isoproterenol-induced hypertrophy in neonatal rat myocytes. Toxicol Lett. 2014 Feb 28;226(3):257-63.
  78. Ruifeng G, Yunhe F, Zhengkai W, et al. Chlorogenic acid attenuates lipopolysaccharide-induced mice mastitis by suppressing TLR4-mediated NF-kappaB signaling pathway. Eur J Pharmacol. 2014 Jan 20;729c:54-58.
  79. Shen W, Qi R, Zhang J, et al. Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurons. Brain Res Bull. 2012 Aug 1;88(5):487-94.
  80. Kang TY, Yang HR, Zhang J, et al. The studies of chlorogenic Acid antitumor mechanism by gene chip detection: the immune pathway gene expression. J Anal Methods Chem. 2013;2013:617243.
  81. Amin RP, Kunaparaju N, Kumar S, Taldone T, Barletta MA, Zito SW. Structure elucidation and inhibitory effects on human platelet aggregation of chlorogenic acid from Wrightia tinctoria. J Complement Integr Med. 2013;10.
  82. Meng S, Cao J, Feng Q, Peng J, Hu Y. Roles of Chlorogenic Acid on Regulating Glucose and Lipids Metabolism: A Review. Evid Based Complement Alternat Med. 2013;2013:801457.
  83. Stefanello N, Schmatz R, Pereira LB, et al. Effects of chlorogenic acid, caffeine, and coffee on behavioral and biochemical parameters of diabetic rats. Mol Cell Biochem. 2014 Mar;388(1-2):277-86.
  84. Bagdas D, Ozboluk HY, Cinkilic N, Gurun MS. Antinociceptive Effect of Chlorogenic Acid in Rats with Painful Diabetic Neuropathy. J Med Food. 2014 Mar 10.
  85. Bagdas D, Cam Etoz B, Inan Ozturkoglu S, et al. Effects of systemic chlorogenic Acid on random-pattern dorsal skin flap survival in diabetic rats. Biol Pharm Bull. 2014 Mar 1;37(3):361-70.
  86. Farah A, Monteiro M, Donangelo CM, Lafay S.Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr . 2008 Dec;138(12):2309-15.
  87. Monteiro M, Farah A, Perrone D, et al.Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr. 2007 Oct;137(10):2196-201.
  88. Cho ES, Jang YJ, Hwang MK, Kang NJ, Lee KW, Lee HJ. Attenuation of oxidative neuronal cell death by coffee phenolic phytochemicals. Mutat Res. 2009 Feb 10;661(1-2):18-24.
  89. Oboh G, Agunloye OM, Akinyemi AJ, Ademiluyi AO, Adefegha SA. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer’s disease and some pro-oxidant induced oxidative stress in rats’ brain-in vitro. Neurochem Res. 2013 Feb;38(2):413-9.